Recent News

Mercury-Containing Dental Amalgam May Have Harmful Health Effects to High-Risk Groups

On September 24th, 2020, the FDA published a press release issuing updated recommendations regarding the potential risks of mercury-containing dental amalgam fillings to high-risk groups. The FDA is issuing these updates as a response to certain risks surrounding the dental fillings that may predominantly impact certain high-risk groups.    Dental Amalgam is a Substance Used…

Read More...

FDA News Release: Opdivo and Yervoy Combination Approved to Treat Mesothelioma

For the first time in 16 years, a drug combination and FDA-approved systemic therapy has been approved to treat malignant pleural mesothelioma that cannot be removed surgically. The first-line treatment for adults will include drug combination therapy using Opdivo (nivolumab) and Yervoy (ipilimumab) to increase the chances of patient survival. Here, the pharmaceutical liability attorneys…

Read More...

Recent FDA News Release: Benzodiazepines Boxed Warning to Be Updated to Include Serious Risks

On September 23rd, the U.S. Food and Drug Administration (FDA) announced that it would be requiring “class-wide labeling changes” for psychoactive drugs that fall under the class of Benzodiazepines. The label change to the Boxed Warning will include benzos’ risks of abuse, dependence, misuse, addiction and potential withdrawal symptoms.  The labeling update is a reaction…

Read More...

Injuries and Deaths from E-Scooter Incidents Have Increased

In recent years, we have experienced a rise in the dependence of automated scooters, such as e-scooters, both as a mode of transportation and as a hobby. From electronic rental scooters scattered around many cities, such as Baltimore, to motorized e-bikes that many are purchasing on their own, these devices are a modern go-to way…

Read More...

Bladder Drug Manufacturers Face Lawsuits Over Retinal Damage Linked to Elmiron

On Wednesday, August 12th, women in two separate complaints filed suit against units of Johnson & Johnson, Bayer and Teva Pharmaceuticals USA Inc. after they developed eye damage after taking bladder medication Elmiron. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the latest updates in Elmiron litigation and what it means for patients…

Read More...

Talc-Based Johnson & Johnson Products Linked to Ovarian Cancer and Mesothelioma

Lawsuits against Johnson & Johnson continue to increase amid claims that talc-based J&J products may cause cancer. If you or someone you know has been diagnosed with ovarian cancer or mesothelioma after using Johnson & Johnson’s talc-based products, such as Baby Powder or Shower to Shower, do not hesitate to seek out legal counsel to…

Read More...

Elmiron Update: Warnings Changed to Include Risk of Eye Damage

On June 16th, 2020,  the Food and Drug Administration (FDA) announced labeling changes to Elmiron, a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the potential dangers to consumers taking Elmiron, and how to seek legal representation…

Read More...

Elmiron Linked to Vision Loss

Elmiron is a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Recently, Elmiron has been linked to the increased risk of pigmentary maculopathy and other forms of vision loss and damage. The pharmaceutical liability attorneys at Peter Angelos P.C. Law are actively investigating cases regarding the use…

Read More...

FDA Requests Removal of Zantac From the Market Immediately

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of possible carcinogenic effects of the contaminant N-nitrosodimethylamine, or NDMA. Here, the pharmaceutical liability attorneys at Peter Angelos, P.C. discuss…

Read More...

Continuation of Monsanto Dicamba Litigation Updates

In August 2019, environmentally conscious public-interest organizations filed a lawsuit against the U.S. Environmental Protection Agency and agrochemical company, Monsanto, after the approval of a pesticide meant for use on soybean and cotton plants. Here, the environmental litigation attorneys at Peter Angelos P.C. discuss the controversy surrounding the damaging dicamba pesticide and how the EPA’s…

Read More...